|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 | |
网站主页 >> 化工产品目录 >> >> 市场分析报告 |
市场分析报告 |
|
Global Market Report of simvastatin acid (CAS 121009-77-6) December 2024 Lovastatin/Simvastatin (CAS 75330-75-5) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Simvastatin acyl-β-D-glucuronide (CAS 463962-56-3) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). EC Number: 604-165-5 1-Naphthaleneheptanoic acid, 8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-beta,??-dihydroxy-2,6-dimethyl-, ammonium salt (1:1), (betaR,??R,1S,2S,6R,8S,8aR)- Chemical Report & Database ... salt (1:1), (betaR,??R,1S,2S,6R,8S,8aR)-: 1-Naphthaleneheptanoic acid, 8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-beta,??-dihydroxy ... ammonium salt (1:1), (betaR,??R,1S,2S,6R,8S,8aR)- Synonyms: Simvastatin acid ammonium salt Chemical Registry number ... Biocon Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... Lipoic Acid, Co-enzyme Q10, L-Carnitine); Cardiovascular Agents (Atorvastatin, Lovastatin, Pravastatin, Simvastatin); Digestive ... companys Statins portfolio comprises Lovastatin, Simvastatin, Pravastatin, and Atorvastatin. Immunosuppressants: ... Research Report on China's Hypolipidemic Drug Market, 2012-2013 ... categories: statins, fibrates, nicotinic acids, resins and cholesterol ... were statins (respectively: Atorvastatin, Simvastatin, Pravastatin and Fluvastatin), ... still statins (respectively: Atorvastatin, Simvastatin, Pravastatin and Fluvastatin), which ... Research Report on Chinese Hypolipidemic Agent Market, 2010-2011 ... into statins, niacins, fibrates, cholic acid chelating agents, polyenes, new-type ... four were all statins (atorvastatin, simvastatin, pravastatin and fluvastatin), of which the ... Dyslipidaemia: KOL Insight ... algorithm? Statin FDC combinations Cholib (simvastatin/fenofibrate; AbbVie): What are the ... either brand? Epanova (omega-3 carboxylic acids; AstraZeneca): What are the key ... Hyperlipidemia Drugs Market Size, Share, Trends and Forecast by Drug Type, End User, and Region, 2025-2033 ... lipid-modifying therapies, including bempedoic acid and gene-silencing treatments, is ... by Drug Type: Statins Bile Acid Sequestrants Cholesterol Absorption Inhibitors ... bring. Statins, atorvastatin, rosuvastatin, and simvastatin will maintain their market ... 2020 COVID-19 Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 ... inhibitor, Acetaminophen, acetylsalicylic acid, adalimumab, Aescinate , AG0301, ... Sildenafil, Silibinin, Siltuximab, Silymarin, simvastatin, Sirolimus, Sirukumab, Sitagliptin, ... , Tradipitant, Tramadol, Tranexamic acid, Tranilast, Trastuzumab, Triazavirin, ... COVID-19 Therapy and Vaccine Drug Pipeline and Clinical Trials Report- September 2020 Update ... inhibitor, Acetaminophen, acetylsalicylic acid, adalimumab, Aescinate , AG0301, ... Sildenafil, Silibinin, Siltuximab, Silymarin, simvastatin, Sirolimus, Sirukumab, Sitagliptin, ... , Tradipitant, Tramadol, Tranexamic acid, Tranilast, Trastuzumab, Triazavirin, ... Hypertriglyceridemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major hypertriglyceridemia markets are expected to exhibit a CAGR of 3.52% during 2024-2034. The hypertriglyceridemia market has been comprehensively analyzed in IMARC's new report titled "Hypertriglyceridemia Market: Epidemiology, Industry Trends, ... Dyslipidemia Therapeutics: Market Research Report This report analyzes the worldwide markets for Dyslipidemia Therapeutics in US$ Million by the following segments - Statins, and Non-Statins. The report provides separate comprehensive analytics for US, Japan, Europe, and Rest of World. Annual estimates ... Heterozygous Familial Hypercholesterolemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major heterozygous familial hypercholesterolemia markets reached a value of US$ 10.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 32.9 Billion by 2034, exhibiting a growth rate (CAGR) of 11.14% during 2024-2034. The ... |